FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approves a supplemental application for Gabapentin from BluePoint Laboratories, updating the existing approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neuropathic Pain
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)